Foto 1 di 1

Foto di catalogo

Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning U - Foto 1 di 1

Selling Sickness : How the World's Biggest Pharmaceutical Companies Are Turning Us All into Patients by Ray Moynihan and Alan Cassels (2006, Perfect)

Zebrasbooks-2 (4348)

99,5% di feedback positivi

Prezzo:

US $13,42

CircaEUR 11,43

+ $19,90 di spese di spedizione

Consegna prevista mar 12 ago - lun 25 ago

Restituzioni:

Restituzioni entro 30 giorni. Le spese di spedizione del reso sono a carico dell'acquirente..

Condizione:

Nuovo

Informazioni su questo prodotto

Product Identifiers

PublisherPublicaffairs

ISBN-10156025856X

ISBN-139781560258568

eBay Product ID (ePID)24038664081

Product Key Features

Number of Pages272 Pages

LanguageEnglish

Publication NameSelling Sickness : How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients

Publication Year2006

SubjectPublic Health, Sociology / General, Industries / Pharmaceutical & Biotechnology, Pharmacology, Disease & Health Issues

TypeTextbook

AuthorRay Moynihan, Alan Cassels

Subject AreaSocial Science, Business & Economics, Medical

FormatPerfect

Dimensions

Item Height0.6 in

Item Weight11.5 Oz

Item Length8.2 in

Item Width5.5 in

Additional Product Features

Intended AudienceTrade

Dewey Edition22

ReviewsRay Moynihan and Alan Cassels examine how the drug industry has transformed the way we think about physical and mental health and turned more and more of us each year into customers.

Dewey Decimal381.456151

SynopsisThirty years ago, Henry Gadsden, the head of Merck, one of the world's largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley's. It had long been his dream to make drugs for healthy people so that Merck could "sell to everyone." Gadsden's dream now drives the marketing machinery of the most profitable industry on earth. Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being "at risk" is sold as a disease. Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt health-care systems all over the world. As more and more of ordinary life becomes medicalized, the industry moves ever closer to Gadsden's dream: "selling to everyone.", Thirty years ago, the head of the drug company Merck made some remarkably candid comments about his distress that his company's market was limited to sick people. Suggesting he would like Merck to be more like the maker of Wrigley's chewing gum, the CEO said it had long been his dream to make drugs for healthy people, to "sell to everyone." That dream now drives the marketing machinery of the most profitable industry on earth. From award-winning Ray Moynihan, -- one of the world's top medical journalists -- Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits. This in turn is driving up personal drug bills and threatening to bankrupt national health systems all over the world. As more and more ordinary life is "medicalized," the industry moves ever closer to being able to "sell to everyone.", Thirty years ago, Henry Gadsden, the head of Merck, one of the world's largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley's. It had long been his dream to make drugs for healthy people so that Merck could sell to everyone. Gadsden's dream now drives the marketing machinery of the most profitable industry on earth. Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being at risk is sold as a disease. Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt health-care systems all over the world.As more and more of ordinary life becomes medicalized, the industry moves ever closer to Gadsden's dream: selling to everyone., Thirty years ago, Henry Gadsden told Fortune that he wanted Merck to be more like chewing gum-maker Wrigley's. It had long been his dream to make drugs for healthy people--to "sell to everyone." Gadsden's dream now drives the marketing machinery of the most profitable industry on earth. Using their dominating influence in the world of medical science, drug companies are systematically working to widen the very boundaries that define illness. Old conditions are expanded and new ones created, and the markets for medication grow ever large. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being "at risk" is sold as a disease in its own right. Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits. As ordinary life becomes increasingly medicalized, the industry moves ever closer to Gadsden's dream: "selling to everyone.", Thirty years ago, Henry Gadsden, the head of Merck, one of the world's largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley's. It had long been his dream to make drugs for healthy people so that Merck could "sell to everyone." Gadsden's dream now drives the marketing machinery of the most profitable industry on earth. Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being "at risk" is sold as a disease. "Selling Sickness" reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt health-care systems all over the world. As more and more of ordinary life becomes medicalized, the industry moves ever closer to Gadsden's dream: "selling to everyone."